Literature DB >> 8530981

Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system.

C A Davie1, A Feinstein, L D Kartsounis, G J Barker, N J McHugh, M J Walport, M A Ron, I F Moseley, W I McDonald, D H Miller.   

Abstract

We examined 13 patients with neurological manifestations of systemic lupus erythematosus (SLE) based on previous and/or current neurological or psychotic episodes by magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy (MRS) together with psychiatric and cognitive assessment. MRI was abnormal in 7 patients, showing high signal lesions in the white matter and/or cerebral atrophy. Proton MRS centred on white matter lesions in 5 patients showed a reduction in the N-acetyl aspartate creatine ratio compared with normal appearing white matter in the SLE group and in 10 healthy controls. This pattern of abnormality does not allow differentiation of SLE lesions from the chronic plaques occurring in multiple sclerosis. There was a very high incidence of current psychiatric morbidity in the SLE group, namely in 12 of the 13 patients. There was no correlation between the presence of current psychiatric involvement and/or cognitive dysfunction and abnormalities detected with MRI or MRS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530981     DOI: 10.1007/bf00867424

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis.

Authors:  P M Matthews; G Francis; J Antel; D L Arnold
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

2.  Cognitive impairment in patients with systemic lupus erythematosus.

Authors:  J G Hanly; J D Fisk; G Sherwood; E Jones; J V Jones; B Eastwood
Journal:  J Rheumatol       Date:  1992-04       Impact factor: 4.666

3.  Psychopathology in systemic lupus erythematosus. I. Psychiatric observations.

Authors:  M Baker
Journal:  Semin Arthritis Rheum       Date:  1973       Impact factor: 5.532

4.  Nervous system involvement in systemic lupus erythematosus.

Authors:  R G Berry; J H Hodges
Journal:  Trans Am Neurol Assoc       Date:  1965

Review 5.  Cerebral disease in systemic lupus erythematosus.

Authors:  E N Harris; G R Hughes
Journal:  Springer Semin Immunopathol       Date:  1985

6.  Neuropsychologic deficits and antineuronal antibodies in pediatric systemic lupus erythematosus.

Authors:  P H Papero; H G Bluestein; P White; R N Lipnick
Journal:  Clin Exp Rheumatol       Date:  1990 Jul-Aug       Impact factor: 4.473

Review 7.  N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain.

Authors:  D L Birken; W H Oldendorf
Journal:  Neurosci Biobehav Rev       Date:  1989       Impact factor: 8.989

8.  Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.

Authors:  D L Arnold; P M Matthews; G S Francis; J O'Connor; J P Antel
Journal:  Ann Neurol       Date:  1992-03       Impact factor: 10.422

9.  Psychiatric and neurological manifestations in systemic lupus erythematosus.

Authors:  L Lim; M A Ron; I E Ormerod; J David; D H Miller; S J Logsdail; M J Walport; A E Harding
Journal:  Q J Med       Date:  1988-01

10.  Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo.

Authors:  H Bruhn; J Frahm; K D Merboldt; W Hänicke; F Hanefeld; H J Christen; B Kruse; H J Bauer
Journal:  Ann Neurol       Date:  1992-08       Impact factor: 10.422

View more
  8 in total

1.  Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus.

Authors:  Gerlof P Th Bosma; Tom W J Huizinga; Simon P Mooijaart; Mark A Van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

2.  Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus.

Authors:  J S Axford; F A Howe; C Heron; J R Griffiths
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

3.  Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study.

Authors:  M Rovaris; B Viti; G Ciboddo; S Gerevini; R Capra; G Iannucci; G Comi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

4.  Biochemical markers of intelligence: a proton MR spectroscopy study of normal human brain.

Authors:  R E Jung; W M Brooks; R A Yeo; S J Chiulli; D C Weers; W L Sibbitt
Journal:  Proc Biol Sci       Date:  1999-07-07       Impact factor: 5.349

5.  The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus.

Authors:  William M Brooks; Wilmer L Sibbitt; Mario Kornfeld; Rex E Jung; Arthur D Bankhurst; Carlos A Roldan
Journal:  Arthritis Rheum       Date:  2010-07

6.  Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up.

Authors:  G Castellino; M Govoni; M Padovan; P Colamussi; M Borrelli; F Trotta
Journal:  Ann Rheum Dis       Date:  2005-01-07       Impact factor: 19.103

Review 7.  Neuropsychiatric Systemic Lupus Erythematosus in Older Adults: Diagnosis and Management.

Authors:  Oshrat E Tayer-Shifman; Kathleen S Bingham; Zahi Touma
Journal:  Drugs Aging       Date:  2021-12-16       Impact factor: 3.923

8.  A clinically isolated syndrome: a challenging entity: multiple sclerosis or collagen tissue disorders: clues for differentiation.

Authors:  Asli Kurne; Ilksen Colpak Isikay; Kader Karlioguz; Umut Kalyoncu; Omer Faruk Aydin; Meral Calguneri; Rana Karabudak
Journal:  J Neurol       Date:  2009-01-21       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.